Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications
- 16 May 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (20) , 1287-1291
- https://doi.org/10.1056/nejm199605163342002
Abstract
Rheumatoid arthritis is a common disease that causes substantial morbidity and mortality. The responses of patients with rheumatoid arthritis to treatment with a single so-called disease-modifying drug, such as methotrexate, are often suboptimal. Despite limited data, many patients are treated with combinations of these drugs.Keywords
This publication has 33 references indexed in Scilit:
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Sulfasalazine in early rheumatoid arthritis. A 48‐week double‐blind, prospective, placebo‐controlled studyArthritis & Rheumatism, 1993
- A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritisArthritis & Rheumatism, 1988
- LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARSThe Lancet, 1987
- A double‐blind, placebo‐controlled trialArthritis & Rheumatism, 1986
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- ADULT AND JUVENILE RHEUMATOID ARTHRITIS: CURRENT EPIDEMIOLOGIC CONCEPTSEpidemiologic Reviews, 1981
- Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.Annals of the Rheumatic Diseases, 1975
- Gold Salts in the Treatment of Rheumatoid ArthritisAnnals of Internal Medicine, 1974
- CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITISThe Lancet, 1973